CRO QPS acquires Qualitix

Wednesday, March 9, 2011

QPS, a global GLP/GCP-compliant CRO providing testing services for preclinical and clinical R&D, has acquired a majority interest of Qualitix Clinical Research. Qualitix, a spin-off of Taiwan-based biotech Genovate, is a CRO and site management organization (SMO) with offices in Taiwan and China. Genovate will retain a minority interest in Qualitix, which will be known as QPS-Qualitix Taiwan.

[Read More]

PPD Named Best CRO in Asia

Thursday, July 1, 2010

PPD was named Best Contract Research Organization (CRO) in Asia at the World Vaccine Congress’ inaugural 2010 Vaccine Industry Excellence (ViE) Asia Awards held in Singapore.

[Read More]

Parexel Adds Two Locations in China

Thursday, May 27, 2010

Parexel has opened two new offices in China, increasing its presence in the Asia-Pacific region to 17 locations, in order to meet growing demand for clinical development and regulatory consulting services from drug sponsors looking for more opportunities to include China in global drug development strategies.

[Read More]

Quintiles Adds Anatomic Pathology Services to China Lab

Tuesday, February 23, 2010

Quintiles added anatomic pathology to the service offerings it provides at its central laboratory in Beijing, China. The new services complement assay development, digital pathology and core lab offerings, which the Beijing facility already offers to help customers comply with China’s restrictions on tissue import and export.

[Read More]